PARAMUS, N.J., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company transforming standard-of-care therapies with…
MADRID and CAMBRIDGE, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical…
Phase 1 study to progress to the next dose level of 75mCi in patients with HER2+ advanced solid tumors, instead…
Also, six new projects from previous NSF/CASIS joint solicitations were selected to advance tissue engineering and transport phenomena research through…
JERSEY CITY, N.J., Sept. 30, 2025 /PRNewswire/ -- OMI Pulse recently received recognition as a recognized quality solution for pathway…
JERSEY CITY, N.J., Sept. 30, 2025 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services,…
UPPSALA, Sweden, Sept. 30, 2025 /PRNewswire/ -- Navinci today announced the launch of the Naveni® Plex Omni Service, a new offering…
The collaboration combines multimodal database technology, advanced AI agents, and large-scale datasets to accelerate drug discovery. SAN FRANCISCO, Sept. 30,…
In this free webinar, understand why traditional 3+3 dose escalation designs are increasingly unsuitable for modern oncology drug development. Attendees…
Nabsys to host a CoLab Session in partnership with Hitachi High-Tech America, Inc. and Boston Children's Hospital PROVIDENCE, R.I., Sept.…